Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.79 +0.68 (+1.41%)
As of: Oct 21, 2026 · 3:32 PM EDT

Rigel Pharmaceuticals (RIGL) Capital Leases (2010)

Updated

Rigel Pharmaceuticals (RIGL) recorded Capital Leases of $45,000 in Q4 2010.

Analysis

Rigel Pharmaceuticals (RIGL) Capital Leases (2010) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn
10 Rigel Pharmaceuticals 905.73 Mn 371.62 Mn 70.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 45,000.00
API Access

Rigel Pharmaceuticals Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=RIGL&period=max&api_key=YOUR_API_KEY